BamSEC and AlphaSense Join Forces
Learn More

Biohaven Pharmaceutical Holding Co Ltd. – Plans of Reorganization, Merger, Acquisition or Similar

Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.2
from 8-K 77 pages Separation and Distribution Agreement by and Among Biohaven Pharmaceutical Holding Company Ltd., Biohaven Research Ltd., And, Solely With Respect to Section 2.7(b), Section 2.10, Section 4.2, Section 4.3, Section 4.5(c), Section 4.7, Section 5.1(a), Section 6.6(i), Section 8.3, Section 8.6, and Section 8.7, Pfizer Inc. Dated as of May 9, 2022
12/34/56
EX-2.1
from 8-K 106 pages Agreement and Plan of Merger by and Among Pfizer Inc., Bulldog (Bvi) Ltd. and Biohaven Pharmaceutical Holding Company Ltd., Dated as of May 9, 2022
12/34/56
EX-2.1
from 10-Q 100 pages Membership Interest Purchase Agreement by and Among Biohaven Therapeutics Ltd., Knopp Biosciences LLC, Channel Biosciences, LLC and Biohaven Pharmaceutical Holding Company Ltd., Solely for the Purpose of Section 9.14 Dated as of February 24, 2022 Certain Confidential Information Contained in This Document, Marked by [**], Has Been Omitted Because It Is Both (I) Not Material and (II) the Type the Registrant Treats as Private or Confidential
12/34/56
EX-2.1
from 8-K 16 pages Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K 20 pages Prv Transfer Agreement by and Between Biohaven Pharmaceutical Holding Ltd and Gw Research, Ltd. March 15, 2019 Prv Transfer Agreement
12/34/56
EX-2.3
from 8-K 20 pages Subscription Agreement Dated as of October 5, 2017 by and Between Kleo Pharmaceuticals, Inc. and Biohaven Pharmaceutical Holding Company Ltd. Common Stock US$0.0001 Par Value
12/34/56
EX-2.2
from 8-K 20 pages Subscription Agreement Dated as of October 5, 2017 by and Between Kleo Pharmaceuticals, Inc. and Biohaven Pharmaceutical Holding Company Ltd. Common Stock US$0.0001 Par Value
12/34/56
EX-2.1
from 8-K 22 pages Securities Purchase Agreement Between Kleo Pharmaceuticals, Inc. and Biohaven Pharmaceutical Holding Company Limited. Dated as of August 29, 2016
12/34/56